Pfizer/Boehringer Ingelheim

Changing the Course of COPD

Remedy worked with Queen’s University to develop a series of tools examining importance of differential diagnosis, role of exacerbations and best practices that help physicians distinguish asthma from chronic obstructive pulmonary disease.